BRIEF-Twist Bioscience Expands Antibody Discovery Offering With Bispecific Licensing Agreement

+3.23% Post

Twist Bioscience

TWST

46.86

+3.23%

0.00% Post

Feb 17 (Reuters) - Twist Bioscience Corp TWST.O:

TWIST BIOSCIENCE EXPANDS ANTIBODY DISCOVERY OFFERING WITH BISPECIFIC LICENSING AGREEMENT
TWIST BIOSCIENCE CORP - ENTERS LICENSING AGREEMENT WITH INVENRA
TWIST BIOSCIENCE CORP - TAKES 6% OWNERSHIP IN INVENRA FOR $13.8 MILLION IN STOCK
TWIST BIOSCIENCE CORP - TO PAY INVENRA 20% ROYALTY ON LICENSE REVENUE

Source text: ID:nBwc2J4mWa

Further company coverage: TWST.O

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.